CoChat

Inflammation and aging: signaling pathways and intervention therapies

Open access
Li, Xia, Li, Chentao, Zhang, Wanying, Wang, Yanan, Qian, Pengxu, Huang, He · 2023 · Signal Transduction and Targeted Therapy

The DOI matches its Crossref record; 476 of the 479 references it cites were found in a registry or an index, and 1 are not checked yet; 215 of the 287 sources its claims cite were checked for support.

Abstract

Aging is characterized by systemic chronic inflammation, which is accompanied by cellular senescence, immunosenescence, organ dysfunction, and age-related diseases. Given the multidimensional complexity of aging, there is an urgent need for a systematic organization of inflammaging through dimensionality reduction. Factors secreted by senescent cells, known as the senescence-associated secretory phenotype (SASP), promote chronic inflammation and can induce senescence in normal cells. At the same time, chronic inflammation accelerates the senescence of immune cells, resulting in weakened immune function and an inability to clear senescent cells and inflammatory factors, which creates a vicious cycle of inflammation and senescence. Persistently elevated inflammation levels in organs such as the bone marrow, liver, and lungs cannot be eliminated in time, leading to organ damage and aging-related diseases. Therefore, inflammation has been recognized as an endogenous factor in aging, and the elimination of inflammation could be a potential strategy for anti-aging. Here we discuss inflammaging at the molecular, cellular, organ, and disease levels, and review current aging models, the implications of cutting-edge single cell technologies, as well as anti-aging strategies. Since preventing and alleviating aging-related diseases and improving the overall quality of life are the ultimate goals of aging research, our review highlights the critical features and potential mechanisms of inflammation and aging, along with the latest developments and future directions in aging research, providing a theoretical foundation for novel and practical anti-aging strategies.

Verified 2026-11-19 · 1 reference not checked yet

Overview

CoChat Summary

## TL;DR

This review argues that inflammaging—a chronic, systemic inflammatory state—is tightly intertwined with cellular senescence, immunosenescence, organ dysfunction, and age-related disease. It synthesizes signaling pathways, aging models, single-cell technologies, and intervention strategies, emphasizing anti-inflammatory approaches, senolytics, stem cell therapy, and organ transplantation.

## Key findings

  • The paper describes a “vicious cycle” in which senescent cells secrete SASP factors that promote chronic inflammation, while chronic inflammation accelerates immune-cell senescence and weakens clearance of senescent cells and inflammatory factors.
  • It highlights reported age-related immune changes across cell types, including decreased circulating naive CD8 T cells as a consistent marker of immunosenescence in healthy older adults, reduced NK-cell cytotoxicity, and age-associated shifts in HSC differentiation toward myeloid lineages.
  • The review links inflammaging to organ-level decline in the bone marrow, thymus, spleen, lymph nodes, brain, heart, kidney, liver, skin, lung, and gut, with examples such as age-related thymic degeneration reducing new T-cell output and aged bone marrow impairing HSC function.
  • For intervention, it notes that the first senolytic combination, dasatinib plus quercetin, increased 6-minute walking distance by an average of 21.5 meters in the first human trial, but other outcomes did not change significantly and long-term efficacy remains insufficiently supported.

## Methods

  • Narrative review of inflammaging across molecular, cellular, organ, and disease levels, with sections on signaling pathways, classical aging models, single-cell technology, and intervention strategies.
  • No new experimental sample or cohort is reported in the paper itself; instead, it synthesizes findings from prior mouse, human, and cell-line studies cited throughout the text.
  • The main approach is qualitative integration of published evidence, including examples from in vitro senescence models, in vivo mouse models, centenarian studies, and emerging single-cell/multi-omics work.

## Limitations

  • The paper explicitly notes that the exact causality between inflammation and aging remains unresolved and “deserves further studies” for effective intervention.
  • It also states that PANoptosis has no direct evidence yet linking it to aging, so any connection is speculative.
  • Evident from the text: this is a broad review rather than a primary study, so many conclusions are synthesized from heterogeneous prior studies rather than tested in one unified dataset.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41392-023-01502-8

Cites

476 of 477 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Inflammaging at the molecular, cellular, and organ levels. During the aging process, almost all cells in the body undergo senescence, a state characterized by a dysfunctional state and senescence-associated secretory phenotype (SASP). While immune cells play a crucial role in recognizing and eliminating these senescent cells, they are also affected by SASP, leading to a phenomenon called immunosenescence. Immunosenescence can impair the immunity to respond to infections and diseases, making the organism more vulnerable to illnesses. Moreover, the accumulation of senescent cells can trigger inflammation in organs, leading to organ damage and an increased risk of age-related diseases. This process is exacerbated by positive feedback loops that drive the accumulation of inflammation and organ damage, leading to further inflammation and an even higher risk of aging-related diseases
Fig. 1 Inflammaging at the molecular, cellular, and organ levels. During the aging process, almost all cells in the body undergo senescence, a state characterized by a dysfunctional state and senescence-associated secretory phenotype (SASP). While immune cells play a crucial role in recognizing and eliminating these senescent cells, they are also affected by SASP, leading to a phenomenon called immunosenescence. Immunosenescence can impair the immunity to respond to infections and diseases, making the organism more vulnerable to illnesses. Moreover, the accumulation of senescent cells can trigger inflammation in organs, leading to organ damage and an increased risk of age-related diseases. This process is exacerbated by positive feedback loops that drive the accumulation of inflammation and organ damage, leading to further inflammation and an even higher risk of aging-related diseasesCC BY · PubMed Central
Fig. 2 Characterization of HSC differentiation into immune cells during aging. Inflammation in senescent bone marrow impairs the function of HSCs. HSCs differentiate into various immune cells, and their senescence leads to changes in the number and functions of immune cells. Common features of immune cell senescence include a decline in performing immune functions and an increase in the release of inflammatory factors
Fig. 2 Characterization of HSC differentiation into immune cells during aging. Inflammation in senescent bone marrow impairs the function of HSCs. HSCs differentiate into various immune cells, and their senescence leads to changes in the number and functions of immune cells. Common features of immune cell senescence include a decline in performing immune functions and an increase in the release of inflammatory factorsCC BY · PubMed Central
Fig. 3 Aging-organ atlas. Aging manifests as a decline in organ function and an increased susceptibility to diseases. Organs are mainly divided into immune organs, sterile organ, and others. Functional changes in cells are shown in each organ
Fig. 3 Aging-organ atlas. Aging manifests as a decline in organ function and an increased susceptibility to diseases. Organs are mainly divided into immune organs, sterile organ, and others. Functional changes in cells are shown in each organCC BY · PubMed Central
Fig. 4 Schematic diagram of six inflammatory cell death molecular patterns. The source of inflammation comes from cell death in addition to the release of SASP from senescent cells. Both immune response-mediated and damage signaling-mediated cell death promote inflammation to some extent. Various modes of cell death (in addition to apoptosis) release large amounts of inflammatory factors
Fig. 4 Schematic diagram of six inflammatory cell death molecular patterns. The source of inflammation comes from cell death in addition to the release of SASP from senescent cells. Both immune response-mediated and damage signaling-mediated cell death promote inflammation to some extent. Various modes of cell death (in addition to apoptosis) release large amounts of inflammatory factorsCC BY · PubMed Central

Verification

Claims the paper makes

140 Valid · 17 Not valid · 39 Not checked · 40 Own results and interpretations

95 more claims · 66 with their cited sources checked

Create a free account to see all 236 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 111
  • Probably not a substantial claim. 41
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 477 references

Cited by

See all 1,443

Metadata

Authors
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H.
Affiliations
  • First Affiliated Hospital Zhejiang University (CN)
  • Zhejiang University-University of Edinburgh Institute (CN)
Corresponding author
  • Qian, Pengxu
  • Huang, He
Venue
Signal Transduction and Targeted Therapy
Published
2023-06-08
Volume
8
Issue
1
Pages
239-239
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4379966446
Cited by
1,443
References
479
Citations by year
2026: 496 · 2025: 592 · 2024: 322 · 2023: 32
FWCI
51.26
Type
journal article
Language
en
Open access
Licence
Locations
  • Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81900176, 92268117, 82130003, 82222003, 82161138028, 82222003, 92268117)
  • National Key Research and Development Program of China (2022YFA1103500)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
inflammaging, aging, chronic inflammation, cellular senescence, immunosenescence, senescence-associated secretory phenotype, senolytics, anti-aging strategies, age-related diseases, organ dysfunction, single-cell technologies, aging models, signaling pathways
MeSH terms
Humans, Inflammation, Quality of Life, Signal Transduction, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation and aging: signaling pathways and intervention therapies. https://app.cochat.ai/papers/10.1038/s41392-023-01502-8
The paper
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023). Inflammation and aging: signaling pathways and intervention therapies. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-023-01502-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.